HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Cao Selected Research

asialoglycophorin

10/2013CD176 antiserum treatment leads to a therapeutic response in a murine model of leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Cao Research Topics

Disease

113Neoplasms (Cancer)
05/2022 - 03/2007
24Neoplasm Metastasis (Metastasis)
04/2022 - 11/2010
22Lung Neoplasms (Lung Cancer)
12/2021 - 01/2012
19Inflammation (Inflammations)
12/2022 - 10/2014
19Stomach Neoplasms (Stomach Cancer)
06/2022 - 02/2012
17Carcinogenesis
07/2021 - 02/2011
11Infections
01/2021 - 10/2008
10Breast Neoplasms (Breast Cancer)
11/2021 - 04/2010
9Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2002
8Rupture
01/2021 - 07/2012
7Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 04/2011
7Hypoxia (Hypoxemia)
11/2021 - 06/2007
6Brain Ischemia (Cerebral Ischemia)
07/2022 - 11/2015
6Atherosclerosis
01/2022 - 02/2016
6Prostatic Neoplasms (Prostate Cancer)
07/2021 - 11/2010
6Liver Diseases (Liver Disease)
04/2021 - 11/2002
6Carcinoma (Carcinomatosis)
03/2020 - 04/2010
5Wounds and Injuries (Trauma)
01/2022 - 07/2016
5Leukemia
01/2017 - 07/2008
4Hemorrhage
12/2022 - 01/2022
4Ischemic Stroke
06/2022 - 11/2016
4Alzheimer Disease (Alzheimer's Disease)
02/2022 - 01/2018
4Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 05/2019
4Stroke (Strokes)
01/2022 - 10/2006
4Colonic Neoplasms (Colon Cancer)
01/2022 - 11/2020
4Chronic Obstructive Pulmonary Disease (COPD)
12/2021 - 01/2018
4Insulin Resistance
11/2021 - 03/2016
4Non-alcoholic Fatty Liver Disease
03/2019 - 08/2015
4Osteoarthritis
02/2019 - 05/2014
3Asthma (Bronchial Asthma)
12/2022 - 11/2006
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/2022 - 01/2020
3Myocardial Infarction
06/2022 - 01/2016
3Heart Failure
06/2022 - 01/2009
3Neuroblastoma
05/2022 - 08/2019
3Cognitive Dysfunction
04/2022 - 01/2014
3Neurodegenerative Diseases (Neurodegenerative Disease)
04/2022 - 01/2018
3Sepsis (Septicemia)
01/2022 - 04/2019
3Cicatrix (Scar)
01/2022 - 12/2009
3Fatigue
01/2022 - 02/2007
3Thrombosis (Thrombus)
01/2022 - 01/2019
3Osteoporosis
11/2021 - 06/2010
3Infarction (Infarctions)
04/2021 - 01/2016
3Thyroid Neoplasms (Thyroid Cancer)
01/2020 - 12/2014
3Endocarditis
01/2020 - 04/2019

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
11/2022 - 10/2003
17Long Noncoding RNAIBA
06/2022 - 01/2017
16MicroRNAs (MicroRNA)IBA
04/2022 - 10/2012
16Pharmaceutical PreparationsIBA
01/2022 - 02/2011
15Biomarkers (Surrogate Marker)IBA
07/2021 - 02/2013
15Contrast MediaIBA
01/2021 - 01/2016
13DNA (Deoxyribonucleic Acid)IBA
10/2020 - 03/2007
11AntigensIBA
04/2022 - 04/2010
11RNA (Ribonucleic Acid)IBA
01/2022 - 03/2015
11Messenger RNA (mRNA)IBA
01/2021 - 09/2008
10CytokinesIBA
09/2021 - 01/2016
8CarbohydratesIBA
01/2018 - 07/2008
7HydrogelsIBA
01/2022 - 08/2018
7EnzymesIBA
01/2021 - 11/2002
6Reactive Oxygen Species (Oxygen Radicals)IBA
12/2022 - 10/2014
6Biological ProductsIBA
04/2022 - 04/2012
6Therapeutic UsesIBA
02/2022 - 08/2017
6LigandsIBA
11/2021 - 01/2017
6Interleukin-6 (Interleukin 6)IBA
07/2021 - 01/2016
6Glucose (Dextrose)FDA LinkGeneric
04/2021 - 01/2015
6GadoliniumIBA
03/2021 - 05/2017
6Carotenoids (Carotene)IBA
03/2019 - 09/2008
5AntioxidantsIBA
01/2022 - 05/2015
5Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2020 - 10/2012
5Transcription Factors (Transcription Factor)IBA
11/2019 - 02/2011
5Thomsen-Friedenreich antigenIBA
06/2016 - 04/2011
4Air Pollutants (Pollutants, Air)IBA
09/2022 - 09/2015
4FlavonoidsIBA
01/2022 - 04/2013
4Glutathione (Reduced Glutathione)IBA
11/2021 - 02/2018
4Glycerol (Glycerine)FDA LinkGeneric
09/2021 - 11/2016
4Oxygen (Dioxygen)IBA
04/2021 - 01/2020
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2020 - 08/2014
4Phosphotransferases (Kinase)IBA
07/2020 - 06/2013
4Doxorubicin (Adriamycin)FDA LinkGeneric
06/2020 - 01/2012
4LipidsIBA
06/2020 - 03/2016
4VaccinesIBA
01/2018 - 01/2008
4SaltsIBA
04/2012 - 06/2007
3tanshinoneIBA
04/2022 - 12/2018
3AcidsIBA
01/2022 - 02/2016
3ChitosanIBA
01/2022 - 01/2016
3Adenosine Triphosphate (ATP)IBA
11/2021 - 02/2011
3Neuroprotective AgentsIBA
09/2021 - 01/2020
3sharpinIBA
07/2021 - 10/2014
3CateninsIBA
01/2021 - 06/2020
3Indicators and Reagents (Reagents)IBA
01/2021 - 08/2010
3PolyproteinsIBA
12/2020 - 02/2007
3Cisplatin (Platino)FDA LinkGeneric
08/2020 - 04/2014
3Peptides (Polypeptides)IBA
08/2020 - 01/2009
3fu-yuanIBA
07/2020 - 06/2012
3SmokeIBA
06/2020 - 09/2015
3Interleukin-17 (Interleukin 17)IBA
01/2020 - 01/2019

Therapy/Procedure

38Therapeutics
07/2022 - 10/2006
9Drug Therapy (Chemotherapy)
07/2021 - 12/2013
7Immunotherapy
04/2022 - 05/2019
3Lasers (Laser)
03/2021 - 04/2017
3Radiotherapy
08/2020 - 05/2019